✦ LIBER ✦

A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma

✍ Scribed by Thomas Yau, P. N. Cheng, Pierre Chan, William Chan, Li Chen, Jimmy Yuen, Roberta Pang, S. T. Fan, Ronnie T. Poon

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 1 dose escalation of ONT-10, a the

✍ John Nemunaitis,Cynthia Bedell,Kevin Klucher… 📂 Article 📅 2013 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 68 KB

A phase I/II study of S-1 with sorafenib

✍ Ooka, Yoshihiko; Chiba, Tetsuhiro; Ogasawara, Sadahisa; Arai, Kuniaki; Suzuki, E 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 166 KB

A phase I dose escalating study of the a

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 266 KB

P49 Escalating weekly fixed-dose of nimo

✍ K. Zhao; G. Jiang; X. Hu; X. Wu; X. Fu; M. Fan; S. Yu; X. Chu; P. Liang; J. Zhen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 45 KB

465 DISCUSSION A Phase 1 dose escalating

✍ S. Sharma; J.C. Bendell; H. Hurwitz; C.H. Condon; B.J. Thornell; P.L. Slatcher; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 60 KB

A phase 1 dose-escalation study of ARRY-

✍ Hanna Jean Khoury; Guillermo Garcia-Manero; Gautam Borthakur; Tapan Kadia; Maria 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB